Bioengineering | Penn Today

As One uCity Square nears capacity, developer plots surrounding innovation campus and hotel addition

David Meaney of the School of Engineering and Applied Science is quoted on a building project that will mark the first time Penn Engineering and Penn Medicine will have operations under the same roof.

Penn biomedical scientists move into new uCity complex with 115,000 square feet of lab space

More than 50 Penn scientists and staff, including the Perelman School of Medicine’s Drew Weissman, are moving into 115,000 square feet of new lab space in the 13-story One uCity Square building.

3d render of T cells attacking cancer cells

A suit of armor for cancer-fighting cells

New research from the University of Pennsylvania offers a safer path for CAR T cell immunotherapy.

A low-cost, eco-friendly COVID test

César de la Fuente and a team of Penn engineers work on creative ways to create faster and cheaper testing for COVID-19. Their latest innovation incorporates speed and cost-effectiveness with eco-friendly materials.

The physics of fat droplets reveal DNA danger

Penn Engineers are the first to discover fat-filled lipid droplets’ surprising capability to indent and puncture the nucleus, the organelle which contains and regulates a cell’s DNA.

For a new generation of antibiotics, scientists are bringing extinct molecules back to life

Marrying artificial intelligence with advanced experimental methods, Penn Engineering’s Machine Biology Group has mined the ancient past for future medical breakthroughs, bringing extinct molecules back to life.

Silicon wafer with chips lightinhg in neon light.

SCALAR: A microchip designed to transform the production of mRNA therapeutics and vaccines

Researchers have developed a platform that could rapidly accelerate the development of mRNA-based lipid nanoparticle vaccines and therapeutics at both the small and largescale, SCALAR.

Microscopic view of a DNA chain disintegrating.

QR code for cancer cells

Researchers from Penn Engineering have created a new synthetic biology approach to uncover why some cells become resistant to anti-cancer therapies.

Scientists turn to human ancestors’ DNA in search for new antibiotics

A study co-authored by César de la Fuente of the School of Engineering & Applied Science recreated molecules from ancient humans that could be potential candidates for antimicrobial treatments.

AI search of Neanderthal proteins resurrects ‘extinct’ antibiotics

A study co-authored by César de la Fuente of the Perelman School of Medicine used artificial intelligence to identify new antibiotic protein snippets produced by ancient humans.

Filters